139 related articles for article (PubMed ID: 9465289)
1. Growth hormone-releasing peptides and their analogs.
Camanni F; Ghigo E; Arvat E
Front Neuroendocrinol; 1998 Jan; 19(1):47-72. PubMed ID: 9465289
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-releasing peptides.
Ghigo E; Arvat E; Muccioli G; Camanni F
Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
[TBL] [Abstract][Full Text] [Related]
3. Age-related growth hormone-releasing activity of growth hormone secretagogues in humans.
Arvat E; Camanni F; Ghigo E
Acta Paediatr Suppl; 1997 Nov; 423():92-6. PubMed ID: 9401552
[TBL] [Abstract][Full Text] [Related]
4. Orally active growth hormone secretagogues: state of the art and clinical perspectives.
Ghigo E; Arvat E; Camanni F
Ann Med; 1998 Apr; 30(2):159-68. PubMed ID: 9667794
[TBL] [Abstract][Full Text] [Related]
5. History to the discovery of ghrelin.
Bowers CY
Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing peptides: clinical and basic aspects.
Argente J; García-Segura LM; Pozo J; Chowen JA
Horm Res; 1996; 46(4-5):155-9. PubMed ID: 8950613
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
8. [Growth hormone-releasing peptides (GHRP) and their analogues].
Korbonits M; Grossman AB
Orv Hetil; 1996 Nov; 137(45):2503-9. PubMed ID: 8999395
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone in obesity.
Scacchi M; Pincelli AI; Cavagnini F
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
[TBL] [Abstract][Full Text] [Related]
10. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.
Arvat E; Di Vito L; Gianotti L; Ramunni J; Boghen MF; Deghenghi R; Camanni F; Ghigo E
Metabolism; 1997 Jan; 46(1):83-8. PubMed ID: 9005975
[TBL] [Abstract][Full Text] [Related]
12. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
Yan M; Hernandez M; Xu R; Chen C
Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
[TBL] [Abstract][Full Text] [Related]
14. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.
Bellone J; Bartolotta E; Sgattoni C; Aimaretti G; Arvat E; Bellone S; Deghenghi R; Ghigo E
J Endocrinol Invest; 1998 Sep; 21(8):494-500. PubMed ID: 9801989
[TBL] [Abstract][Full Text] [Related]
15. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
Rigamonti AE; Bonomo SM; Cella SG; Müller EE
J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
[TBL] [Abstract][Full Text] [Related]
16. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.
Arvat E; Ceda GP; Di Vito L; Ramunni J; Gianotti L; Broglio F; Deghenghi R; Ghigo E
Pituitary; 1998 Apr; 1(1):51-8. PubMed ID: 11081183
[TBL] [Abstract][Full Text] [Related]
17. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
Giustina A; Bonfanti C; Licini M; Ragni G; Stefana B
Regul Pept; 1997 May; 70(1):49-54. PubMed ID: 9250581
[TBL] [Abstract][Full Text] [Related]
18. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
Korbonits M; Little JA; Forsling ML; Tringali G; Costa A; Navarra P; Trainer PJ; Grossman AB
J Neuroendocrinol; 1999 Jul; 11(7):521-8. PubMed ID: 10444309
[TBL] [Abstract][Full Text] [Related]
20. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
